André Paixão

ORCID: 0000-0003-2271-2685
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Coronary Interventions and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Peripheral Artery Disease Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Valve Diseases and Treatments
  • Vascular Procedures and Complications
  • Cardiovascular Health and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Hemodynamic Monitoring and Therapy
  • Congenital Heart Disease Studies
  • Cardiac Arrhythmias and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • ECG Monitoring and Analysis
  • Transplantation: Methods and Outcomes
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Physical Activity and Health
  • Enhanced Recovery After Surgery
  • Vasculitis and related conditions
  • Cardiac tumors and thrombi

Arkansas Heart Hospital
2016-2025

Instituto Politécnico de Santarém
2024

The University of Texas Southwestern Medical Center
2013-2019

Southwestern Medical Center
2019

Rabin Medical Center
2019

Universidade Federal de São Carlos
2019

University of Arkansas for Medical Sciences
2016-2017

Hospital de Santa Maria
2017

University of Lisbon
2017

Emory University
2015-2016

Francisco Ujueta Gervasio A. Lamas Kevin J. Anstrom Ana Navas‐Acién Robin Boineau and 95 more Yves Rosenberg Mario Stylianou Teresa L.Z. Jones Bonnie R. Joubert Qilu Yu Jun Wen Hayley Nemeth Zhen Huang Vivian Fonseca David M. Nathan Gabriel I. Uwaifo Ivan A. Arenas Lan Luo Jeffrey Baker Diana Visentin André Paixão John F. Schmedtje Daniel B. Mark Philip Bear Donna Prouty Jodi Baxter Jonathan K. Ehrman Heather Golden Vikrant Katoch Raffi K. Krikorian André Paixão Fujiko Anazawa Leybi Ramirez-Kelly Abby Nolen Venus Barney Gerald Natzke Rodica Pop‐Busui Cindy Plunkett Laura Meyer J. Kirk Roberts Scott A. Rollins Tamra Hollis Nampalli Vijay Melinda Washam David Zidar Terence Semenec Lauren Huntington Amanda Klumpp Matthew S. Doughty Jeffrey Baker Joseph P. Allen Rebecca Cortez Bhaskar Purushottam Kirstin Stauffacher Kelly J. Airey Elena Christofides Jordyn Conway David Hoffman Patty Schuler Ronald M Solbrig Loni Chacon Phillip D. Levy Linda Gojcevic R. Eric Collins John Miles McClure Ellen Mook Christopher R. deFilippi Wendy Sheaffer Antoinette Bonaccorso Daniel Donovan Julee Hartwell Andrew P. Garner Dawn Kalbfliesh David H. Hsi Maryanne Ducey Paula Trump Urs A. Leuenberger Katie Loffredo Betty Persico Allan Magaziner Dennis Goodman Michela L. Garabedian J. Coates Jeanne P. Wingo Sheldon H. Gottlieb Michael Schächter Sally Minniefield Olakunle Akinboboye Kazi Masel Ullah Karen Wolske Dennis Friedman Daniel Lorber M. Tsovian Regina Druz Patricia Hodnett Stephanie Meller Maria B. Bartolome Giselle Cortez Vargas Ian Ergui Francisco Ujueta

Importance In 2013, the Trial to Assess Chelation Therapy (TACT) reported that in 1708 patients with stable coronary disease and prior myocardial infarction (MI), oral multivitamins multiminerals (OMVMs), a factorial design edetate disodium (EDTA) chelation therapy, did not reduce cardiovascular events relative placebo OMVMs, but active EDTA combined OMVMs was superior OMVM/placebo EDTA. Objective To compare OMVM vs terms of efficacy for reducing major adverse diabetes MI. Design, Setting,...

10.1001/jamainternmed.2024.8408 article EN cc-by JAMA Internal Medicine 2025-03-03
Gervasio A. Lamas Kevin J. Anstrom Ana Navas‐Acién Robin Boineau Hayley Nemeth and 95 more Zhen Huang Jun Wen Yves Rosenberg Mario Stylianou Teresa L.Z. Jones Bonnie R. Joubert Qilu Yu Regina M. Santella Ana C. Mon Francisco Ujueta Esteban Escolar David M. Nathan Vivian Fonseca Y. Wady Aude Jonathan K. Ehrman T.S.J. Elliott Rakesh Prashad Eldrin F. Lewis Renato D. Lopes Michael E. Farkouh Anne-Marie Elliott Jonathan Newman Daniel B. Mark Philip Bear Donna Prouty Jodi Baxter Jonathan K. Ehrman Heather Golden Vikrant Katoch Raffi K. Krikorian André Paixão Fujiko Anazawa Leybi Ramirez-Kelly Abby Nolen Venus Barney Gerald Natzke Rodica Pop‐Busui Cindy Plunkett Laura Meyer J. Kirk Roberts Scott A. Rollins Tamra Hollis Nampalli Vijay Melinda Washam David Zidar Terence Semenec Lauren Huntington Amanda Klumpp Matthew S. Doughty Jeffrey Baker Joseph P. Allen Rebecca Cortez Bhaskar Purushottam Kirstin Stauffacher Kelly J. Airey Elena Christofides Jordyn Conway David Hoffman Patty Schuler Ronald M Solbrig Loni Chacon Phillip D. Levy Linda Gojcevic R. Eric Collins John Miles McClure Ellen Mook Christopher R. deFilippi Wendy Sheaffer Antoinette Bonaccorso Daniel Donovan Julee Hartwell Andrew P. Garner Dawn Kalbfliesh David H. Hsi Maryanne Ducey Paula Trump Urs A. Leuenberger Katie Loffredo Betty Persico Allan Magaziner Dennis Goodman Michela L. Garabedian J. Coates Jeanne P. Wingo Sheldon H. Gottlieb Michael Schächter Sally Minniefield Olakunle Akinboboye Kazi Masel Ullah Karen Wolske Dennis Friedman Daniel Lorber M. Tsovian Regina Druz Patricia Hodnett

In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior myocardial infarction (MI).

10.1001/jama.2024.11463 article EN JAMA 2024-08-14

Background: Prediabetes defined by fasting plasma glucose (FPG) and glycosylated haemoglobin (HbA1c) predicts incident diabetes, but their individual joint associations with micro- macro-vascular risk remain poorly defined. Methods: FPG, HbA1c, coronary artery calcium (CAC), carotid wall thickness, estimated glomerular filtration rate (eGFR) urine albumin-to-creatinine ratio (UACR) were measured in adults free from prior diabetes or cardiovascular disease (CVD) the Dallas Heart Study 2...

10.1177/1479164113514239 article EN Diabetes and Vascular Disease Research 2013-12-16

10.1161/circoutcomes.114.001139 article EN Circulation Cardiovascular Quality and Outcomes 2014-08-06

The absence of coronary artery calcium (CAC) in middle age is associated with very low short-term risk for events. However, the long-term implications a CAC score 0 are uncertain, particularly among individuals high cardiovascular lifetime risk. We sought to characterize association between predicted and incident risk.We included 754 Dallas Heart Study participants serial scans (6.9 years apart) both baseline CAC=0. Lifetime disease was estimated according factor burden. Among this group,...

10.1161/jaha.114.001280 article EN cc-by-nc-nd Journal of the American Heart Association 2014-11-26

Background: Current diagnostic criteria for cardiogenic shock (CS) require the use of a pulmonary artery catheter (PAC), which is time-consuming and may cause complications. A set simple yet accurate noninvasive would be significant utility. Methods: Candidate components Noninvasive Parameters Assessment Cardiogenic Shock (N-PACS) were required to objective, readily available, noninvasive. Variables encompassing hypotension, hypoperfusion, predisposing conditions, elevated intracardiac...

10.1177/2048872614534564 article EN European Heart Journal Acute Cardiovascular Care 2014-05-15

A 52-year-old woman with a history of hypertension presented to the emergency department chest pain that started while sitting at work 2 hours previously. She described as “someone on her chest” and reported associated diaphoresis shortness breath.

10.1001/jama.2014.5554 article EN JAMA 2014-11-16

Abstract Background Original descriptions of the takotsubo syndrome (TS) included a characteristic left ventricular (LV) contraction pattern, “apical ballooning.” Recently, several reports have associated patterns not strictly conforming to original description with TS. The specifics pattern seem set TS apart from much larger population patients acute coronary (ACS) but no obstructive artery disease (OCAD). This study was undertaken compare midventricular and apical dysfunction those other...

10.1002/clc.20833 article EN Clinical Cardiology 2011-01-01

A invisibilidade social, muitas vezes imperceptível à primeira vista, se caracteriza pela ação de tornar algo ou alguém despercebido, ignorado desvalorizado. Este estudo visa evidenciar a das mulheres na terceira idade, explorando as questões que envolvem o envelhecimento feminino e destacando necessidade urgente práticas cuidados específicos para esse grupo. metodologia adotada é qualitativa, foi desenvolvido por meio da Revisão Integrativa Literatura (RIL), permitiu análise artigos estudos...

10.69849/revistaft/fa10202411300716 article PT Revista fisio&terapia. 2024-11-30
Coming Soon ...